Gold prices bounce off 3-week lows; demand likely longer term
Daniel L. Weiner, a director at Simulations Plus , Inc. (NASDAQ:SLP), recently sold 750 shares of the company's common stock. The shares were sold at a price of $28.50 each, totaling $21,375. The transaction comes as the stock trades near its 52-week low of $27.07, with the company currently valued at $562 million. This transaction was conducted automatically under a pre-established Rule 10b5-1 trading plan. Following this sale, Weiner holds 7,236 shares in the company. The sale was reported in a regulatory filing submitted on December 30, 2024. According to InvestingPro analysis, Simulations Plus maintains strong financial health with liquid assets exceeding short-term obligations and operates with moderate debt levels. The company's next earnings report is scheduled for January 7, with analysts recently revising earnings estimates upward.
In other recent news, Simulations Plus has been making significant strides in both its financial performance and research collaborations. The company ended fiscal year 2024 with an 18% rise in total revenue to $70 million, and a fourth-quarter revenue increase of 19% to $18.7 million. Despite falling short of the $19.7 million consensus estimate, the company issued financial guidance for fiscal year 2025 that included revenue projections aligning with initial estimates.
Simulations Plus has also been awarded a grant by the U.S. Food and Drug Administration for a collaborative project with the University of Strathclyde and InnoGI Technologies. This initiative aims to advance understanding and prediction of amorphous solid dispersion formulations under various conditions.
Furthermore, the company's strategic acquisitions of Pro-ficiency and Immunetrics have broadened its market reach and enhanced its software offerings. Despite challenges in the Asian market, Simulations Plus remains optimistic, projecting a revenue of $90 million to $93 million for fiscal year 2025.
Finally, BTIG has adjusted the financial outlook for Simulations Plus, reducing the price target to $50.00 from the previous $60.00, while maintaining a Buy rating on the stock. This adjustment comes in light of the company's recent financial performance and market expectations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.